check_circleStudy Completed
Hypertension, Pulmonary
Bayer Identifier:
90570
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Safety follow-up study of inhaled iloprost in patients with pulmonary hypertension
Trial purpose
The aim of this study is to monitor long-term safety and tolerability of iloprost aerosol inhalation therapy in patients suffering from pulmonary hypertension.
Key Participants Requirements
Sex
BothAge
18 - 71 YearsTrial summary
Enrollment Goal
71Trial Dates
February 2000 - August 2005Phase
Phase 3Could I Receive a placebo
NoProducts
Ventavis (Iloprost, BAYQ6256)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Instytut Gruzlicy i Chorob Pluc | Warszawa, 01138, Poland |
Completed | Ciutat Sanitària i Universitaria de la Vall d'Hebrón | Barcelona, 08035, Spain |
Completed | CHU Reims, Hopital Robert Debre | REIMS, 51092, France |
Completed | Hopital Antoine Beclere | Clamart Cedex, 92141, France |
Completed | Hopital Claude-Huriez CHRU | Lille, 59037, France |
Completed | Università di Pisa | Pisa, 56100, Italy |
Completed | UZ Leuven Gasthuisberg | LEUVEN, 3000, Belgium |
Completed | Hospital Universitario 12 de Octubre | Madrid, 28041, Spain |
Completed | Hopital Albert Calmette | Lille, 59037, France |
Completed | Hopital Bretonneau | Tours Cedex, 37044, France |
Completed | Vrije Universiteit Medisch Centrum | AMSTERDAM, 1081 HV, Netherlands |
Completed | C.H.U. - Hopital Nord | Grenoble Cedex 9, 38043, France |
Completed | Università di Bologna | Bologna, 40138, Italy |
Completed | Centro Medico di Montescano | Montescano, 27040, Italy |
Completed | Centro Hospitalar Vila Nova de Gaia | Vila Nova de Gaia, 4434-506, Portugal |
Completed | Hospitais da Universidade de Coimbra | Coimbra, 3000-076, Portugal |
Completed | Hôpital Erasme/Erasmus Ziekenhuis | BRUXELLES, 1070, Belgium |
Primary Outcome
- Adverse eventsdate_rangeTime Frame:Throughout the whole studyenhanced_encryptionNoneSafety Issue:
Secondary Outcome
- Tolerability of treatmentdate_rangeTime Frame:Over a minimum of 24 monthsenhanced_encryptionNoneSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
Non-randomizedBlinding
Open LabelAssignment
Single Group AssignmentTrial Arms
1